EpiPen maker Mylan faces proposed class action lawsuit in U.S.
Tuesday, April 4, 2017 - 10:01
in Mathematics & Economics
Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $600 US for a two-pack of the device from less than $100 in 2007.